Fresenius Medical Care AG & Co. KGaA Cash Flow Conversion Efficiency

Latest as of March 2026: 0.016x

Fresenius Medical Care AG & Co. KGaA cash flow conversion efficiency. Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FMEA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€226.89 Million ≈ $265.25 Million USD) by net assets (€14.20 Billion ≈ $16.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Fresenius Medical Care AG & Co. KGaA (2016–2025)

Cash flow conversion efficiency of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. This chart illustrates how Fresenius Medical Care AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View FMEA stock price for real-time trading data and today's change.

Fresenius Medical Care AG & Co. KGaA Cash Flow Conversion Ratio Explained

Fresenius Medical Care AG & Co. KGaA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Fresenius Medical Care AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their cash flow conversion efficiency. Also see FMEA stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
China Shipbuilding Industry Group Power Co Ltd SHG:600482	0.044x
Groep Brussel Lambert NV BR:GBLB	0.038x
Knight Transportation Inc NYSE:KNX	0.044x
Discovery Holdings Ltd JSE:DSY	0.085x
Peric Special Gases Co. Ltd. A SHG:688146	N/A
Joint Stock Commercial Bank for Investment and Development of Vietnam VN:BID	-0.123x
Resolution Minerals Ltd American Depositary Shares NASDAQ:RML	N/A
LG Corp KO:003550	0.003x

Annual Cash Flow Conversion Efficiency for Fresenius Medical Care AG & Co. KGaA (2016–2025)

The table below shows the annual cash flow conversion efficiency of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. Review FMEA free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€14.28 Billion ≈ $16.70 Billion	€2.68 Billion ≈ $3.13 Billion	0.188x	+24.04%
2024-12-31	€15.77 Billion ≈ $18.44 Billion	€2.39 Billion ≈ $2.79 Billion	0.151x	-14.65%
2023-12-31	€14.83 Billion ≈ $17.33 Billion	€2.63 Billion ≈ $3.07 Billion	0.177x	+26.38%
2022-12-31	€15.45 Billion ≈ $18.06 Billion	€2.17 Billion ≈ $2.53 Billion	0.140x	-21.22%
2021-12-31	€13.98 Billion ≈ $16.34 Billion	€2.49 Billion ≈ $2.91 Billion	0.178x	-48.12%
2020-12-31	€12.33 Billion ≈ $14.42 Billion	€4.23 Billion ≈ $4.95 Billion	0.343x	+76.89%
2019-12-31	€13.23 Billion ≈ $15.46 Billion	€2.57 Billion ≈ $3.00 Billion	0.194x	+21.43%
2018-12-31	€12.90 Billion ≈ $15.08 Billion	€2.06 Billion ≈ $2.41 Billion	0.160x	-21.05%
2017-12-31	€10.83 Billion ≈ $12.66 Billion	€2.19 Billion ≈ $2.56 Billion	0.202x	+14.14%
2016-12-31	€10.89 Billion ≈ $12.74 Billion	€1.93 Billion ≈ $2.26 Billion	0.177x	--

About Fresenius Medical Care AG & Co. KGaA

F:FMEA Germany Medical Care Facilities

Market Cap

$12.81 Billion

€10.96 Billion EUR

Market Cap Rank

#2189 Global

#466 in Germany

Share Price

€20.40

Change (1 day)

+2.00%

52-Week Range

€17.70 - €23.60

All Time High

€37.68